West Oak Capital, LLC Novartis Ag Transaction History
West Oak Capital, LLC
- $2.59 Billion
- Q1 2025
A detailed history of West Oak Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, West Oak Capital, LLC holds 18,913 shares of NVS stock, worth $2.07 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
18,913
Previous 18,778
0.72%
Holding current value
$2.07 Million
Previous $18.3 Million
15.38%
% of portfolio
0.82%
Previous 0.65%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,490Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$896 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$752 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...